HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul R Jenkins Selected Research

fascaplysine

10/2006Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
8/2006CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.
3/2006Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin.
8/2004New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul R Jenkins Research Topics

Disease

6Neoplasms (Cancer)
11/2014 - 08/2004
1Lung Neoplasms (Lung Cancer)
11/2014
1Prostatic Neoplasms (Prostate Cancer)
08/2012

Drug/Important Bio-Agent (IBA)

4fascaplysineIBA
10/2006 - 08/2004
3Biological ProductsIBA
08/2012 - 08/2004
3tryptamineIBA
08/2006 - 08/2004
1Cyclin B1IBA
11/2014
1Tumor Viral Antigens (Large T Antigen)IBA
11/2014
1Proteins (Proteins, Gene)FDA Link
11/2014
13',4',5'-trimethoxyflavonolIBA
08/2012
13-hydroxyflavoneIBA
08/2012
1fisetinIBA
08/2012
1QuercetinIBA
08/2012
1FlavonolsIBA
08/2012
1Antineoplastic Agents (Antineoplastics)IBA
08/2012
1Cyclin-Dependent Kinase 4IBA
10/2006
1Retinoblastoma ProteinIBA
08/2006